Page last updated: 2024-11-02

oxybutynin and Thoracic Neoplasms

oxybutynin has been researched along with Thoracic Neoplasms in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Thoracic Neoplasms: New abnormal growth of tissue in the THORAX.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garzón-Rodríguez, C1
Casals Merchan, M1
Calsina-Berna, A1
López-Rómboli, E1
Porta-Sales, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Preventive Application Of Lidocaine Patch In Adjunction To Intravenous Morphine Analgesia For Management Of Post-Thoracotomy Pain: Results Of A Randomized, Double Blind, Placebo Controlled Study[NCT02751619]90 participants (Actual)Interventional2013-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for oxybutynin and Thoracic Neoplasms

ArticleYear
Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:11

    Topics: Anesthetics, Local; Breast Neoplasms; Cicatrix; Female; Follow-Up Studies; Humans; Lidocaine; Male;

2013